GU ASCO annual meeting featured a session on emerging trends in germ cell tumors and a presentation by Dr. Darren Feldman discussing the landscape of new trials and targets in refractory germ cell ...
ASCO GU 2025: High-Dose Chemotherapy in Testicular Cancer: Current Evidence and Clinical Indications
Both Indiana University and Memorial Sloan Kettering Cancer Center (MSKCC) have published their series’ of salvage high-dose chemotherapy, Indiana using the carboplatin + etoposide regimen and MSKCC ...
Brown rice is less milled, or processed, than white rice. This increases its nutritional value. Learn who stands to benefit from brown rice, plus recipes.
Cells have surface receptors called integrins that bind to repetitive domains present on the extracellular matrix (ECM) surrounding the cells, allowing them to grow and spread. A new study from the ...
Becoming the second drug approved by the U.S. FDA for tenosynovial giant cell tumors, Deciphera Pharmaceuticals Inc.’s oral ...
The Food and Drug Administration (FDA) has approved Romvimza â„¢ (vimseltinib) for the treatment of adult patients with symptomatic tenosynovial giant cell tumor (TGCT) for which surgical resection will ...
The immune systems of cancer patients are highly disrupted, with those who have a higher number of immune cells in their blood having a better survival rate, finds a new study that uses a pioneering ...
Patients with localized muscle-invasive bladder cancer (MIBC) who received radiation plus the immune checkpoint inhibitors (ICIs) durvalumab (Imfinzi) and tremelimumab (Imjudo) had durable responses ...
A new study led by recent undergraduate student Caitlyn Nojiri and co-authored by astronomy and astrophysics professor Enrico ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results